{"id":"https://openalex.org/W1876352928","doi":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","title":"Drug\u2013drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition","display_name":"Drug\u2013drug interactions in the treatment of HIV infection: focus on pharmacokinetic enhancement through CYP3A inhibition","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-14","ids":{"openalex":"https://openalex.org/W1876352928","doi":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","mag":"1876352928","pmid":"https://pubmed.ncbi.nlm.nih.gov/21073558"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2796.2010.02301.x","doi":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.2010.02301.x","source":{"id":"https://openalex.org/S29157290","display_name":"Journal of Internal Medicine","issn_l":"0954-6820","issn":["0954-6820","1365-2796"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Internal Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1876352928"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.2010.02301.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055039896","display_name":"Filip Josephson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1319126558","display_name":"Medical Products Agency","ror":"https://ror.org/0356c4a29","country_code":"SE","type":"government","lineage":["https://openalex.org/I1319126558"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"F. Josephson","raw_affiliation_strings":["Medical Products Agency, Uppsala, Sweden. filip.josephson@mpa.se","Medical Products Agency Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Products Agency, Uppsala, Sweden. filip.josephson@mpa.se","institution_ids":["https://openalex.org/I1319126558"]},{"raw_affiliation_string":"Medical Products Agency Uppsala, Sweden","institution_ids":["https://openalex.org/I1319126558"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055039896"],"corresponding_institution_ids":["https://openalex.org/I1319126558"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.9415,"has_fulltext":true,"cited_by_count":79,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.6581849,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"268","issue":"6","first_page":"530","last_page":"539"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.968999981880188},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cyp3a-inhibition","display_name":"CYP3A inhibition","score":0.9100000262260437},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pharmacokinetic-enhancement","display_name":"pharmacokinetic enhancement","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ritonavir-boosting","display_name":"ritonavir boosting","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cyp3a","display_name":"CYP3A","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9610000252723694},{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9760000109672546},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.8870000243186951},{"id":"https://openalex.org/keywords/acid-reducing-agents","display_name":"acid-reducing agents","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyp3a-inhibitors","display_name":"CYP3A inhibitors","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8673268556594849},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8331118822097778},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7435615062713623},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6563472747802734},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6427785158157349},{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.6287398338317871},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.482669860124588},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.4156894385814667},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.274713397026062},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.20674920082092285},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.1951327919960022},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18544822931289673},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.16428694128990173},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.14673826098442078},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2796.2010.02301.x","doi":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.2010.02301.x","source":{"id":"https://openalex.org/S29157290","display_name":"Journal of Internal Medicine","issn_l":"0954-6820","issn":["0954-6820","1365-2796"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:21073558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21073558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of internal medicine","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2796.2010.02301.x","doi":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2796.2010.02301.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.2010.02301.x","source":{"id":"https://openalex.org/S29157290","display_name":"Journal of Internal Medicine","issn_l":"0954-6820","issn":["0954-6820","1365-2796"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Internal Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1876352928.pdf","grobid_xml":"https://content.openalex.org/works/W1876352928.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W170465674","https://openalex.org/W173494530","https://openalex.org/W1790788819","https://openalex.org/W1871950822","https://openalex.org/W1884434960","https://openalex.org/W1959444897","https://openalex.org/W1964545773","https://openalex.org/W1967951091","https://openalex.org/W1969620637","https://openalex.org/W1975248171","https://openalex.org/W1976580747","https://openalex.org/W1978353805","https://openalex.org/W1984277888","https://openalex.org/W1999830882","https://openalex.org/W2002011163","https://openalex.org/W2002176535","https://openalex.org/W2006069153","https://openalex.org/W2013258544","https://openalex.org/W2030021013","https://openalex.org/W2034618224","https://openalex.org/W2034665713","https://openalex.org/W2035412462","https://openalex.org/W2044330754","https://openalex.org/W2047207059","https://openalex.org/W2052991207","https://openalex.org/W2054641701","https://openalex.org/W2059024430","https://openalex.org/W2067274937","https://openalex.org/W2077434641","https://openalex.org/W2087829259","https://openalex.org/W2088787526","https://openalex.org/W2095442537","https://openalex.org/W2095597897","https://openalex.org/W2105540175","https://openalex.org/W2112857740","https://openalex.org/W2118783130","https://openalex.org/W2118964190","https://openalex.org/W2132697467","https://openalex.org/W2141779363","https://openalex.org/W2146921865","https://openalex.org/W2148710732","https://openalex.org/W2151695776","https://openalex.org/W2314026148","https://openalex.org/W2326797329","https://openalex.org/W4251307042"],"related_works":["https://openalex.org/W4288762993","https://openalex.org/W2080707095","https://openalex.org/W2343886578","https://openalex.org/W1520921895","https://openalex.org/W1805006579","https://openalex.org/W4362454651","https://openalex.org/W1987004599","https://openalex.org/W2398034404","https://openalex.org/W1965002367","https://openalex.org/W2059270623"],"abstract_inverted_index":{"Josephson":[0],"F.":[1],"(Medical":[2],"Products":[3],"Agency,":[4],"Uppsala,":[5],"Sweden).":[6],"Drug\u2013drug":[7],"interactions":[8,42],"in":[9,44,99],"the":[10,37,45,59,93,114,125,140,147],"treatment":[11,47,94],"of":[12,31,39,48,95,127,142,149],"HIV":[13,49],"infection:":[14],"focus":[15],"on":[16,92,113,124,130],"pharmacokinetic":[17,40,79],"enhancement":[18,80],"through":[19],"CYP3A":[20],"inhibition":[21],"(Review\u2010Symposium).":[22],"J":[23],"Intern":[24],"Med":[25],"2010;":[26],"268:":[27],"530\u2013539.":[28],"The":[29,87],"aim":[30],"this":[32],"review":[33],"is":[34,67],"to":[35,58,69,139,145],"discuss":[36],"effect":[38,126],"drug\u2013drug":[41],"(DDIs)":[43],"antiretroviral":[46,71,132],"infection.":[50],"In":[51],"particular,":[52],"but":[53],"not":[54],"exclusively,":[55],"DDIs":[56],"due":[57],"cytochrome":[60],"P450":[61],"3A":[62],"(CYP3A)":[63],"inhibitor":[64],"ritonavir,":[65],"which":[66],"used":[68],"increase":[70],"drug":[72],"exposure":[73],"\u2013":[74],"a":[75],"technique":[76],"known":[77],"as":[78,110,112],"or":[81],"\u2018ritonavir":[82],"boosting\u2019\u2013":[83],"will":[84,90,152],"be":[85,91,153],"reviewed.":[86],"emphasis":[88],"here":[89],"important":[96],"co\u2010morbidities":[97],"common":[98],"patients":[100],"with":[101,137],"HIV,":[102],"including":[103],"dyslipidaemia,":[104],"hypertension,":[105],"tuberculosis":[106],"and":[107,120,123],"opiate":[108],"dependence,":[109],"well":[111],"potentially":[115],"life\u2010threatening":[116],"interaction":[117],"between":[118],"ritonavir":[119],"inhalational":[121],"steroids,":[122],"acid\u2010reducing":[128],"agents":[129,144],"some":[131],"drugs.":[133],"Finally,":[134],"further":[135],"developments":[136],"regard":[138],"use":[141],"CYP3A\u2010blocking":[143],"augment":[146],"efficacy":[148],"antiviral":[150],"therapy":[151],"discussed.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1876352928","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
